Fiji vs Gambia: Access to anti-retroviral drugs, male
Fiji
28.0%
in 2024
Gambia
27.0%
in 2024
Fiji rank
133rd
Gambia rank
136th
Access to anti-retroviral drugs, male over time
- Fiji
- Gambia
How they compare
Fiji currently reports 28.0% against 27.0% in Gambia, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Gambia ahead.
Fiji ranks 133rd and Gambia ranks 136th of 141 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Gambia in 1.
Head to head by decade
| Decade | Fiji | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.2% | 1.4% | 39.8% | Fiji |
| 2010s | 33.5% | 12.2% | 21.3% | Fiji |
| 2020s | 19.6% | 22.2% | 2.6% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Fiji or Gambia?
- Fiji, at 28.0% against 27.0% in Gambia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Fiji and Gambia?
- 1.0%, with Fiji ahead.
- How many years of comparable data are there for Fiji and Gambia?
- 25 years are reported by both, from 2000 to 2024.
- How do Fiji and Gambia rank globally for access to anti-retroviral drugs, male?
- Fiji ranks 133rd and Gambia ranks 136th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.